ICON Strategic Solutions

ICON recently received a 2024 Scrip award for Best Contract Research Organisation - Full Service Providers. This recognition follows a number of accolades in the second half of 2024, including TIME Magazine’s 2024 list of World’s Best Companies and its 2025 list of World’s Best Companies in Sustainable Growth. Read more about ICON’s recent successes here: https://ow.ly/a4Zj50UuNQ1 #ICONCares #leadership #ClinicalResearch

Determine drug efficacy sooner with tumour growth rate (TGR) modelling in your study. Learn about TGR modelling's advantages over other conventional biomarker imaging methods in our new whitepaper. https://ow.ly/c01E50TT4UY #medicalimaging #oncology

As the year comes to a close, we want to thank our employees, clients, and partners around the world. Your dedication, innovation, and collaboration have defined our success and made a meaningful impact on global healthcare throughout 2024. Wishing you and your loved ones a joyful holiday season and a healthy, prosperous New Year. Here’s to continued progress and transformation in 2025!

Targeted product profiles are an essential element of success for oncology treatment developers, yet they are underutilised by most developers according to our recent survey. Read this PharmaTimes article which outlines how developers can stand out in a diverse, uncertain landscape. https://ow.ly/UxMj50UqruS

As 2024 draws to a close, it’s a time for reflection on the achievements of the past year and anticipation for the opportunities ahead in 2025. At ICON Strategic Solutions, our people are at the heart of our success. If you’re looking to the year ahead and exploring new career opportunities, we invite you to join our Talent Communities. Stay connected, discover the latest roles, and keep up to date with news and insights. https://ow.ly/Cw0j50UsApX

At ICON, our Biometrics team delivers high-quality, data-driven solutions that drive success in clinical trials worldwide. With award-winning leadership, a focus on mentorship through programs like Bridge2Lead, and a culture that nurtures innovation, we’re transforming clinical research outcomes every day. Take a look at the video below to learn about what makes our Biometrics team unique in their approach. Explore careers with ICON Biometrics and become part of a leading team in 2025. https://ow.ly/ii4z50UspwI

Medical writing is where science meets communication, and it plays a pivotal role in the healthcare and clinical research industries. Whether you're curious about this field or considering it as a career path, our latest blog dives into everything you need to know. https://ow.ly/z76y50UrQGK

We were honored to host Merck leadership at our Chennai office, commemorating 10 years of successful collaboration. This strategic visit provided an opportunity to evaluate our shared achievements whilst focusing on our continued partnership, operational excellence, and strategic growth opportunities for 2025 and beyond This milestone represents the strength of our long-term partnership and reinforces our commitment to delivering clinical research solutions. We look forward to strengthening this valuable relationship in the years ahead.

In 2023, ICON became a member of Pride Connection Mexico, the largest Diversity and Inclusion alliance in LATAM. On November 23, 2024, our team proudly represented ICON at the Pride Connection Mexico Summit in Mexico City. With nearly 10,000 attendees and the support of an outstanding group of volunteers from our local office, the event was a remarkable opportunity to showcase ICON's career opportunities. It also allowed us to connect with professionals across industries and emphasize our commitment to fostering a strong culture of Diversity, Inclusion, and Belonging. Why not view all our current opportunities in LATAM: https://ow.ly/xez850UpffZ

EMA Policy 0070 aims to increase clinical trial transparency to aid future research. In 2025 it will apply to all new active substances and COVID products. Sponsors must protect patient privacy and ensure the data shared contains enough detail to be useful. Our blog has advice on getting the balance right. https://ow.ly/82E150Uo42f